0000950170-24-034156.txt : 20240320
0000950170-24-034156.hdr.sgml : 20240320
20240320160704
ACCESSION NUMBER: 0000950170-24-034156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240318
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaufmann Petra
CENTRAL INDEX KEY: 0001905589
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 24767828
MAIL ADDRESS:
STREET 1: C/O AFFINIA THERAPEUTICS INC.
STREET 2: 43 FOUNDRY AVE, SUITE 120
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vigil Neuroscience, Inc.
CENTRAL INDEX KEY: 0001827087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FORGE ROAD
STREET 2: SUITE 700
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-254-4445
MAIL ADDRESS:
STREET 1: 100 FORGE ROAD
STREET 2: SUITE 700
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
ownership.xml
4
X0508
4
2024-03-18
0001827087
Vigil Neuroscience, Inc.
VIGL
0001905589
Kaufmann Petra
VIGIL NEUROSCIENCE, INC.
100 FORGE ROAD, SUITE 700
WATERTOWN
MA
02472
false
true
false
false
Chief Medical Officer
false
Stock Option Grant (Right to Buy)
3.14
2024-03-18
4
A
false
330000
0.00
A
2034-03-18
Common Stock
330000
330000
D
This stock option award was issued subject to the terms of the Issuer's 2021 Stock Option and Incentive Plan and shall vest as follows: 25% of the shares shall be vested on March 18, 2025 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter.
/s/ Christopher Verni, Attorney-in-Fact
2024-03-20